Results 211 to 220 of about 3,617,077 (391)

Jianqu, a traditional Chinese medicine, alleviates functional dyspepsia in high-calorie and high-protein diet mice

Jingyan Yang, Xiaoxing Li, Juan Chen, Yanjun Liu, Yue-Hong Wu, Ning-Yu Luo, Cai-Xia Yang, Yang Li, Sijing Liu, Jinlin Guo   +9 more
openalex   +1 more source

THE CLINICAL INTELLECTION DEVELOPMENT (BASED ON CBCR MODEL) IN INTERNAL MEDICINE BY CLINICAL CASE EXAMPLE: PRELIMINARY PULMONARY HYPERTENSION

, 2018
Vitaliy Seredyuk
openalex   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines. [PDF]

J Pharm Policy Pract
Jenei K.
europepmc   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Pensando o processo saúde doença: a que responde o modelo biomédico?

Saúde e Sociedade
Com o propósito de efetuar uma crítica ao modelo biomédico, mecanicista, hegemônico na doutrina e prática que informa a medicina na atualidade, o texto parte de uma síntese histórico-evolutiva que contempla a apresentaçao das idéias e personagens chave ...
José Augusto C. Barros
doaj  

Use of medications with pharmacogenomic guidelines and adverse outcomes in hospitalised older patients: a retrospective cross-sectional study. [PDF]

Pharmacogenomics J
David V, McInerney CD, Tomlinson J, Bryant E, Sagoo GS, Cheong VL, Smith H, Fylan B, Rattray M.   +8 more
europepmc   +1 more source

SP-101: Theranostics In Nuclear Medicine

, 2019
Kelvin Siu Hoong Loke
openalex   +1 more source

Tropical medicine [PDF]

The Lancet, 1991
openaire   +4 more sources

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source